One medicine, a different record in every market.
Each market records the same medicine in its own way. Finding it everywhere means searching every register, one by one.
Example data. Orvanitinib and the companies shown are fictional.
Global pharmaceutical intelligence, simplified.
Market, IP and competitive intelligence, matched to the molecule and updated every day.
Each market records the same medicine in its own way. Finding it everywhere means searching every register, one by one.
SentinelMedX links every record to its molecule, strength and dosage form. Each register then fills gaps in the others, from formulation and excipients to manufacturing and supply sites.
Every market authorisation on one globe, in the order it was granted. Follow the originator’s footprint and the competitors coming after it.
Patents, extensions and exclusivities sit beside each market authorisation, so you can tell at a glance which markets are protected, contested or open.
Save any search as a monitor. When a new market authorisation lands in Australia, or anywhere else you watch, you know that day.
One workspace for market authorisations, protections, competitors and news, all built on the same matched records. Every record links back to its official register entry.
| Authority | Product | Strength | Form | Authorised | Source |
|---|---|---|---|---|---|
| AU | Orvanitinib AshgroveAshgrove Generics | 40 mg | Film-coated tablet | 11 Jun 2026 | Register entry |
| UK | Orvanitinib KestrelKestrel Pharma | 40 mg | Film-coated tablet | 2 Apr 2026 | Register entry |
| US | Orvanitinib KestrelKestrel Pharma | 40 mg | Film-coated tablet | 18 Nov 2025 | Register entry |
| RU | OrvexaNorthvale Therapeutics | 40 mg | Film-coated tablet | 21 Jun 2023 | Register entry |
| JP | OrvexaNorthvale KK | 20 mg, 40 mg | Film-coated tablet | 20 Jan 2022 | Register entry |
| US | OrvexaNorthvale Therapeutics | 40 mg | Film-coated tablet | 14 Mar 2021 | Register entry |
| Market | Originator authorised | First generic | Competitors | Status |
|---|---|---|---|---|
| US United States | Mar 2021 | Nov 2025 | 2 | Contested |
| AU Australia | May 2021 | Jun 2026 | 1 | Contested |
| EU European Union | Aug 2021 | None yet | 0 | Protected to May 2033 |
| JP Japan | Jan 2022 | None yet | 0 | Protected to Nov 2033 |
| KR South Korea | Jun 2022 | None yet | 0 | Open |
| TW Taiwan | Aug 2022 | None yet | 0 | Open |
| BR Brazil | Feb 2023 | Jul 2025 | 1 | Contested |
Twenty-eight websites, eighteen languages and a spreadsheet that is out of date by Friday.
One search, one record per molecule, and an alert the day something changes.
Spot open markets, gaps in a competitor’s footprint and the partners already registered there.
Find precedent market authorisations and timelines across agencies before you file.
Plan entry against competitor authorisations and the protections still in force.
See patents and exclusivities beside the products they cover, with the source one click away.
A 30-minute walkthrough with the molecules and markets you care about.